PROF Profile
Profound Medical Corp., a commercial-stage medical device company, specializes in the development and commercialization of magnetic resonance-guided ablation technologies. The company's innovative solutions are designed for the treatment of prostate disease, uterine fibroids, and palliative pain management. Profound Medical operates in several key markets, including Canada, Germany, the United States, and Finland, leveraging its advanced technology to enhance therapeutic options in these regions.
The company's flagship product, the TULSA-PRO system, utilizes magnetic resonance imaging (MRI) for precision-guided ablation procedures. This system is employed in hospitals and treatment facilities to provide a minimally invasive approach for treating prostate conditions. By integrating MRI guidance with ablation technology, TULSA-PRO offers a targeted and effective solution for prostate disease, improving patient outcomes and reducing the risks associated with traditional surgical methods.
In addition to the TULSA-PRO system, Profound Medical offers the Sonalleve platform, which is a therapeutic system designed for treating uterine fibroids and providing palliative pain relief associated with metastatic bone disease. The Sonalleve system employs high-intensity focused ultrasound (HIFU) to deliver non-invasive treatments, making it a valuable tool for managing uterine fibroids and alleviating pain in cancer patients. This platform underscores the company’s commitment to advancing non-invasive medical technologies.
Founded and headquartered in Mississauga, Canada, Profound Medical Corp. continues to drive innovation in the field of medical devices. The company’s focus on magnetic resonance-guided ablation and non-invasive treatment solutions reflects its dedication to improving patient care through advanced technology. With a robust portfolio of products and a strong presence in key international markets, Profound Medical is well-positioned to advance the future of medical treatments and expand its impact on global healthcare.
|
